Famvir · DIN 02177102 · 500 mg · tablet
Limited Use, Reason for Use code 147 requiredMarketed · checked November 17, 2026
StatusLimited Use, Reason for Use code 147 required
Write on scriptReason for Use code 147 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 147
Reason for Use code 147
Herpes zoster in patients 50 years of age or older, up to 72 hours* after appearance of lesions. Dose: 500mg 3 times/day for 7 days.
Coverage limit:
*The patient must begin treatment within the time frame specified for the product to be reimbursed. There is no benefit from the therapy begun after this time frame.
Coverage limit:
Network will limit supply to 7 days and 21 tablets.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Famvir · DIN 02177102
Manufacturer: Atnahs Pharma UK Limited; listing date 1996-10-01
Health Canada: Marketed since 2025-02-13 · brand FAMVIR · ATC J05AB09 FAMCICLOVIR · form Tablet · route Oral · ingredients FAMCICLOVIR 500 MG · company Searchlight pharma inc · schedule Prescription
Ministry pays: $4.2591 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02177102)
Source record
DIN 02177102: Famvir
Raw flags: sec12=Y, sec3=Y
Item: 081800011; group id 88; item number 0158; lccId 00008; manufacturer id APU
Source form: Tab; strength: 500mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $7.7438; ministry $4.2591
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02177102
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18768
Interchangeable products
Apo-Famciclovir · DIN 02292068 · $4.2591
Shortage status: not checked (no credentials)